Research Initiative Treatment Action (RITA!); Vol 8, No. 1 Summer 2002

www.fda.gov - FDA home page with consumer education material, press releases, industry guidance, bulletins for health professionals, and other information and data.

Office of Special Health Issues - a special office of the FDA that answers questions about the FDA's activities related to HIV/AIDS, cancer, the Patient Representative Program, and other special health issues. For assistance or information contact:

Richard Klein
Food and Drug Administration
Office of Special Health Issues
5600 Fishers Lane, F-12
Rockville, MD 20857
voice: 301.827.4460
fax: 301.443.4555
e-mail: Rklein@oc.fda.gov

list.nih.gov/archives/fda-hiv-aids.html - electronic service providing timely notice via e-mail of product approvals, significant labeling changes, safety warnings, notices of upcoming meetings, and alerts to proposed regulatory guidances for public comment.

Federal Register - a governmental publication issued daily (Monday through Friday), carrying all proposed and finalized regulations and significant legal notices. Notices of the FDA's public meetings and advisory committee meetings are published in the Federal Register. Each notice contains the date, time, and place of the meeting, as well as the agenda. The Federal Register is available through libraries in printed form or it may be accessed through the Internet at www.access.gpo.gov/su_docs/.

FDA News Page - a website that contains information about new FDA issues that are open for public comment at www.fda.gov/opacom/hpnews.html.

FDA Advisory Committee Information Line - 800.741.8138 (or 301.443.0572 in the Washington, DC area). A 5-digit code is assigned to each advisory committee. Information for a particular advisory committee meeting can be obtained by dialing the 800 telephone number above and then the 5-digit code. Some pertinent advisory committee codes follow:

Biological Response Modifiers Advisory Committee - 12389
Vaccine and Related Biological Products Advisory Committee - 12391
Antiviral Drugs Advisory Committee - 12531
Oncologic Drugs Advisory Committee - 12542

888.INFO.FDA (888.463.6332) - toll-free general information and referral line.

800.TRIALS.A (800.874.2572) - toll-free number for information about current HIV/AIDS trials underway in the United States, provided by the AIDS Clinical Trials Information Service (ACTIS).

www.fda.gov/foi/foia2.htm - the FDA's Electronic Freedom of Information Reading Room.

For additional information or to make a Freedom of Information request in writing, contact:

Freedom of Information Staff (HFI-35)
FDA
5600 Fishers Lane
Rockville, MD 20857
fax: 301.443.1726
Note: proprietary or confidential information cannot be obtained through a Freedom of Information request.

For guidance on how to comment on proposals and submit petitions to the FDA, consult "From Test Tube to Patient: Improving Health Through Human Drugs" (p. 96), which can be found on the Internet at www.fda.gov/cder/about/whatwedo/testtube.pdf.

20020710
RI020704

Copyright © 2002 - Research Initiative Treatment Action (RITA!). Reproduced with permission. RITA! is published by The Center for AIDS. Contact Thomas Gegeny, MS, ELS, Editor, RITA! for permission to reproduce RITA!. tom@centerforaids.org. http://www.centerforaids.org

ÆGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1985, 2002. ÆGiS . All materials appearing on ÆGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS , or the party credited as the provider of the content.